Contract facts
8ANNo full NAICS 622110 intel page yet. Browse NAICS intelligence
PHLEBOTOMIST is a federal 8AN award for W40m Usa Hca held by Akahi Associates, LLC. Estimated value $6.8M ($3M obligated). Current period of performance ends Sep 30, 2027. Last award drew 1 bidder. Place of performance: JBSA FT SAM HOUSTON TX. Related solicitation W81K0023Q0075.
Recompete timing
PublicCurrent PoP ends Sep 30, 2027 (405 days remaining). Agencies typically plan 12–18 months ahead — position before the PoP clock runs out.
Incumbent footprint
Public recordAkahi Associates, LLC — $21.0M obligated across 15 awards (firm-wide, all agencies).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract W81K0023C0011?
W81K0023C0011 (Phlebotomist) is a W40m Usa Hca award with a potential value of $6.8M, currently held by Akahi Associates, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is W81K00-23-C-0011?
W81K00-23-C-0011 is the dashed form of PIID W81K0023C0011 (Phlebotomist), held by Akahi Associates, LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded W81K0023C0011?
W40m Usa Hca awarded W81K0023C0011 to Akahi Associates, LLC (potential $6.8M).
Who is the incumbent on W81K0023C0011?
Akahi Associates, LLC is the incumbent with $21.0M across 15 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2027.
When does Akahi Associates, LLC’s W81K0023C0011 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 30, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
